Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 26.37 USD -1.31% Market Closed
Market Cap: 3.6B USD
Have any thoughts about
Perrigo Company PLC?
Write Note

Relative Value

The Relative Value of one PRGO stock under the Base Case scenario is 89.33 USD. Compared to the current market price of 26.37 USD, Perrigo Company PLC is Undervalued by 70%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRGO Relative Value
Base Case
89.33 USD
Undervaluation 70%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
74
Median 3Y
1.1
Median 5Y
1.2
Industry
2.6
Forward
0.8
vs History
vs Industry
Median 3Y
-48
Median 5Y
-34.3
Industry
23
Forward
10
vs History
50
vs Industry
36
Median 3Y
15.5
Median 5Y
13.9
Industry
17.8
vs History
77
vs Industry
25
Median 3Y
14.6
Median 5Y
14.6
Industry
25.4
vs History
92
vs Industry
67
Median 3Y
0.9
Median 5Y
1
Industry
2.2
vs History
85
vs Industry
61
Median 3Y
1.6
Median 5Y
1.9
Industry
2.8
Forward
1.4
vs History
92
vs Industry
48
Median 3Y
4.7
Median 5Y
5.5
Industry
5.4
vs History
73
vs Industry
31
Median 3Y
12.3
Median 5Y
13
Industry
13.7
Forward
9.1
vs History
68
vs Industry
14
Median 3Y
32.3
Median 5Y
33.7
Industry
17.2
Forward
12
vs History
39
vs Industry
24
Median 3Y
26.2
Median 5Y
20.6
Industry
16.5
vs History
28
vs Industry
19
Median 3Y
30.7
Median 5Y
30.7
Industry
19.3
vs History
92
vs Industry
67
Median 3Y
0.8
Median 5Y
0.8
Industry
2

Multiples Across Competitors

PRGO Competitors Multiples
Perrigo Company PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IE
Perrigo Company PLC
NYSE:PRGO
3.6B USD 0.8 -22.5 11.3 27.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
777.8B USD 19 92.9 49.9 55.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 34.9 24.3 27.7
US
Johnson & Johnson
NYSE:JNJ
367.4B USD 4.2 25 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
250B USD 4 20.6 13 16.2
CH
Roche Holding AG
SIX:ROG
209.3B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
180.7B CHF 4.2 12.7 10 14.9
UK
AstraZeneca PLC
LSE:AZN
154.9B GBP 4 30.7 169 253.3
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
IE
Perrigo Company PLC
NYSE:PRGO
Average P/E: 33.6
Negative Multiple: -22.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
34.9
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.7
21%
UK
AstraZeneca PLC
LSE:AZN
30.7
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top